HeartSciences Inc. (HSCS) has a negative trailing P/E of -0.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -124.23%.
Criteria proven by this page:
Overall SharesGrow Score: 38/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2020 | -1.5 | 0.00 | 17.85 | 87.77 | - |
| 2021 | -2.3 | 0.07 | -2.95 | 220.02 | - |
| 2022 | -1.2 | -0.02 | -0.93 | 392.55 | - |
| 2023 | -1.1 | 0.00 | 29.14 | 1,304.65 | - |
| 2024 | -0.5 | 0.00 | 0.45 | 175.12 | - |
| 2025 | -0.4 | 0.01 | 16.05 | 757.08 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2020 | $-115.69 | $64.18K | $-3.83M | -5973.4% |
| 2021 | $-77.89 | $25.6K | $-2.58M | -10081.1% |
| 2022 | $-137.94 | $14.37K | $-4.58M | -31851.8% |
| 2023 | $-6,173.88 | $5.15K | $-490.85M | -9531151.3% |
| 2024 | $-18.74 | $18.6K | $-6.61M | -35511.9% |
| 2025 | $-9.34 | $4.35K | $-8.77M | -201499.5% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-3.44 | $-4.88 – $-2.00 | $50K | $33.87K – $66.13K | 1 |
| 2027 | $-3.02 | $-4.28 – $-1.75 | $350K | $237.1K – $462.9K | 1 |
| 2028 | $-2.21 | $-3.14 – $-1.28 | $3.2M | $3.18M – $3.23M | 1 |
